Nordic Issuing

Ongoing case

Cessatech A/S

Back to all cases

Cessatech A/S

27 Oct - 9 Nov 2022Rights issue

The Danish pharmaceutical company Cessatech A/S specializes in research and development of an analgesic nasal spray for children. Cessatech’s spray is intended to be used in hospitals for acute pain and in connection with medical procedures.

Read more on the Company's website

The offer in summary

Record date: 25 October 2022

Subscription period: 27 October - 9 November 2022

Subscription rights: Those who on the record date 25 October 2022 were registered as shareholders have preferential rights to subscribe for new shares in the rights issue. For one (1) existing share held on the record date the holder receives one (1) unit right. Four (4) unit rights entitle the subscription for one (1) unit. One (1) unit consists of six (6) shares and three (3) warrants of series TO2.

Subscription price: 12,00 DKK

Emission volume: 1.528.133 units

Trading with rights: 25 October - 7 November 2022

Marketplace: Spotlight Stock Market

Financial advisor: Translution Capital


Due to restrictions in applicable law in the United States, Canada, Australia, Hong Kong, Singapore, South Africa, Switzerland, New Zealand, Japan, Russia, Belarus or other countries where participation requires further prospectuses, registrations or actions other than those under Swedish law, the offer to subscribe for securities in this offer is not directed at persons or others with registered address in any of these countries.